PTGS1 and melanoma: In addition to an increase in cDC1 and modest elevation of T cell populations, Ptgs1/Ptgs2−/− BRAFV600E melanomas showed a prominent early rise in NK1.1+CD3− cells (Figure 2A), which was sustained over several days (Figure S2A).